Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta[...]
European Society for Medical Oncology (ESMO) Congress 2024 – Poster
KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy[...]
08/22/2024 | Press release | Archived content
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact